Articles scientifiques

A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer.

Auteurs : Baselga J, Morales SM, Awada A, Blum JL, Tan AR, Ewertz M, Cortes J, Moy B, Ruddy KJ, Haddad T, Ciruelos EM, Vuylsteke P, Ebbinghaus S, Im E, Eaton L, Pathiraja K, Gause C, Mauro D, Jones MB, Rugo HS
Année : 2017
Journal : Breast Cancer Res Treat
Volume : 163(3)
Pages : 535-544

Monitoring molecular response in adult T-cell leukemia by high-throughput sequencing analysis of HTLV-1 clonality.

Auteurs : Artesi M, Marçais A, Durkin K, Rosewick N, Hahaut V, Suarez F, Trinquand A, Lhermitte L, Asnafi V, Avettand-Fenoel V, Burny A, Georges M, Hermine O, Van den Broeke A
Année : 2017
Journal : Leukemia
Volume : 31
Pages : 2532-35

Sequential tumor-directed and lobar radioembolization before major hepatectomy for hepatocellular carcinoma.

Auteurs : Vouche M, Degrez T, Bouazza F, Delatte P, Gomez Galdon M, Hendlisz A, Flamen P, Donckier V
Année : 2017
Journal : World J Hepatol
Volume : 9
Pages : 1372-1377

Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USA.

Auteurs : Ades F, Senterre C, Zardavas D, de Azambuja E, Popescu R, Piccart-Gebhart M
Année : 2017
Journal : PLoS One
Volume : 12(3)
Pages : e0172351

Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.

Auteurs : Lambertini M, Cinquini M, Moschetti I, Peccatori FA, Anserini P, Valenzano Menada M, Tomirotti M, Del Mastro L
Année : 2017
Journal : Eur J Cancer
Volume : 71
Pages : 25-33

The PREgnancy and FERtility (PREFER) study: an Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients.

Auteurs : Lambertini M, Anserini P, Fontana V, Poggio F, Iacono G, Abate A, Levaggi A, Miglietta L, Bighin C, Giraudi S, DAlonzo A, Blondeaux E, Buffi D, Campone F, Merlo DF, Del Mastro L
Année : 2017
Journal : BMC Cancer
Volume : 17
Pages : 346

Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE).

Auteurs : Loibl S, de la Pena L, Nekljudova V, Zardavas D, Michiels S, Denkert C, Rezai M, Bermejo B, Untch M, Lee SC, Turri S, Urban P, Kümmel S, Steger G, Gombos A, Lux M, Piccart-Gebhart M, Von Minckwitz G, Baselga J, Loi S
Année : 2017
Journal : Eur J Cancer
Volume : 85
Pages : 133-145

Corrigendum to 3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259]."

Auteurs : Cardoso F, Costa A, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Bhattacharyya G, Biganzoli L, Cardoso MJ, Carey L, Corneliussen-James D, Curigliano G, Dieras V, El Saghir N, Eniu A, Fallowfield L, Fenech D, Francis P, Gelmon K, Gennari A, Harbeck N, Hudis C, Kaufman B, Krop I, Mayer M, Meijer H, Mertz S, Ohno S, Pagani O, Papadopoulos E, Peccatori F, Penault-Llorca F, Piccart-Gebhart M, Pierga JY, Rugo H, Shockney L, Sledge G, Swain S, Thomssen C, Tutt A, Vorobiof D, Xu B, Norton L, Winer E
Année : 2017
Journal : Breast
Volume : 32
Pages : 269-270

Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia.

Auteurs : Stamatopoulos B, Timbs A, Bruce D, Smith T, Clifford R, Robbe P, Burns A, Vavoulis DV, Lopez L, Antoniou P, Mason J, Dreau H, Schuh A
Année : 2017
Journal : Leukemia
Volume : 31(4)
Pages : 837-45

The incidence of symptomatic brain metastases from extra-pulmonary small cell carcinoma: Is there a role for prophylactic cranial irradiation in a clinically relevant population cohort?

Auteurs : De Caluwe A, Bowering G, Nichol A, Hsu F
Année : 2017
Journal : Radiother Oncol
Volume : 124
Pages : 31-37

Somatic mutations reveal asymmetric cellular dynamics in the early human embryo.

Auteurs : Ju YS, Martincorena I, Gerstung M, Petljak M, Alexandrov LB, Rahbari R, Wedge DC, Davies HR, Ramakrishna M, Fullam A, Martin S, Alder C, Patel N, Gamble S, OMeara S, Giri DD, Sauer T, Pinder SE, Purdie CA, Borg Å, Stunnenberg H, van de Vijver M, Tan BK, Caldas C, Tutt A, Ueno NT, van t Veer LJ, Martens JW, Sotiriou C, Knappskog S, Span PN, Lakhani SR, Eyfjörd JE, Børresen-Dale AL, Richardson A, Thompson AM, Viari A, Hurles ME, Nik-Zainal S, Campbell PJ, Stratton MR
Année : 2017
Journal : Nature
Volume : 543
Pages : 714-718

Network meta-analysis of second-line treatment in metastatic renal cell carcinoma: efficacy and safety.

Auteurs : El Rassy E, Aoun F, Sleilaty G, Kattan J, Banyurwabuke B, Zanaty M, Bakouny Z, Albisinni S, Peltier A, Roumeguere T
Année : 2017
Journal : Future Oncol
Volume : 13
Pages : 2709-2717

Legends in Urology.

Auteurs : Van Velthoven R
Année : 2017
Journal : Can J Urol
Volume : 24
Pages : 8872-8874

Data on HO-1 and CD200 protein secretion during T-cells and mesenchymal stromal cells co-cultures.

Auteurs : Fayyad-Kazan M, Fayyad-Kazan H, Merimi M, Meuleman N, Bron D, Lagneaux L, Najar M
Année : 2017
Journal : Data Brief
Volume : 11
Pages : 442-445

Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies.

Auteurs : Lambertini M, Ceppi M, Cognetti F, Cavazzini G, De Laurentiis M, De Placido S, Michelotti A, Bisagni G, Durando A, Valle E, Scotto T, De Censi A, Turletti A, Benasso M, Barni S, Montemurro F, Puglisi F, Levaggi A, Giraudi S, Bighin C, Bruzzi P, Del Mastro L
Année : 2017
Journal : Eur J Cancer
Volume : 71
Pages : 34-42

Indocyanine green fluorescence-guided surgery after IV injection in metastatic colorectal cancer: A systematic review.

Auteurs : Liberale G, Bourgeois P, Larsimont D, Moreau M, Donckier V, Ishizawa T
Année : 2017
Journal : Eur J Surg Oncol
Volume : 43(9)
Pages : 1656-1667

Foreskin as a source of immunotherapeutic mesenchymal stromal cells.

Auteurs : Najar M, Lagneaux L
Année : 2017
Journal : Immunotherapy
Volume : 9(2)
Pages : 207-217

Mediastinal Grey Zone Lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the LYSA.

Auteurs : Sarkozy C, Molina T, Ghesquières H, Michallet AS, Dupuis J, Damotte D, Morsschauser F, Parrens M, Martin L, Dartigues P, Stamatoullas A, Hirsch P, Fabiani B, Bouabdallah K, Gomes Da Silva M, Maerevoet M, Laurent C, Coiffier B, Salles G, Traverse-Glehen A
Année : 2017
Journal : Haematologica
Volume : 102(1)
Pages : 150-9

Weight loss, fever and arthralgia in a 43-year-old man treated for follicular lymphoma.

Auteurs : Vandeputte M, Couturier B, Vandergheynst F, Maerevoet M, Jullie ML, Kolivras A, Fontanges Q, Verset L, André J, Cogan E, Boysson H
Année : 2017
Journal : Rev Med Interne
Volume : 38(9)
Pages : 633-637

HER2-overexpressing breast cancers amplify FGFR signaling upon acquisition of resistance to dual therapeutic blockade of HER2.

Auteurs : Hanker AB, Garrett JG, Estrada MV, Moore PD, Ericsson PG, Koch JP, Langley E, Singh S, Kim PS, Frampton GM, Sanford EM, Owns P, Becker J, Groseclose MR, Castellino S, Joensuu H, Huober J, Brase JC, Samira M, Brohée S, Venet D, Brown D, Baselga J, Piccart-Gebhart M, Sotiriou C, Arteaga CL
Année : 2017
Journal : Clin Cancer Res
Volume : 23(15)
Pages : 4323-4334